NEW YORK – Eurofins Genomics today announced it has acquired Blue Heron Biotech.
Blue Heron, based in Bothell, Washington, specializes in gene synthesis and DNA design.
"Since DNA oligonucleotides play an integral role in genes, the deal will bolster Blue Heron's production capabilities as well as expand Eurofins Genomics' gene portfolio into cloning and complex gene constructs," Eurofins Genomics said in a statement. The firm added that the acquisition strengthens its offerings in the synthetic biology market.
Financial and other terms of the deal were not disclosed.